Abstract
Systemic lupus erythematosus (SLE) is a chronic and complex autoimmune disease of unknown etiology, characterized by the presence of widespread immunological abnormalities and multiorgan injury. An important advance over the past decade has been our understanding of how different genetic loci (or genes) may dictate specific immune abnormalities in lupus. “Genetic dissection” has unveiled some of the mystery enshrouding lupus pathogenesis. It appears that there are at least two distinct events leading to disease. The first involves a breach in the adaptive immune system and the second involves a dysregulation of innate immunity. Co-ordinate dysregulation of both checkpoints is necessary for full-blown lupus to ensue. The challenge ahead is to understand how these two checkpoints are regulated in human SLE, and to devise therapeutic strategies that target both checkpoints.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Andrews, B.S., Eisenberg, R.A., Theofilopoulos, A.N., Izui, S., Wilson, C.B., McConahey, P.J., Murphy, E.D., Roths, J.B. and Dixon, F.J. (1978) Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J. Exp. Med. 148, 1198–1215.
Baechler, E.C., Gregersen, P.K. and Behrens, T.W. (2004) The emerging role of interferon in human systemic lupus erythematosus. Curr. Opin. Immunol. 16, 801–807.
Banchereau, J. and Steinman, R.M. (1998) Dendritic cells and the control of immunity. Nature 392, 245–252.
Bennett, L., Palucka, A.K., Arce, E., Cantrell, V., Borvak, J., Banchereau, J. and Pascual, V. (2003) Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 197, 711–723.
Blanco, P., Palucka, A.K., Gill, M., Pascual, V. and Banchereau, J. (2001) Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 294, 1540–1543.
Braun, D., Geraldes, P. and Demengeot, J. (2003) Type I interferon controls the onset and severity of autoimmune manifestations in lpr mice. J. Autoimmun. 20, 15–25.
Crow, M.K. and Kirou, K.A. (2004) Interferon-alpha in systemic lupus erythematosus. Curr. Opin. Rheumatol. 16, 541–547.
Davidson, A. and Aranow, C. (2006) Pathogenesis and treatment of systemic lupus erythematosus nephritis. Curr. Opin. Rheumatol. 18, 468–475.
Ding, D., Mehta, H., McCune, W.J. and Kaplan, M.J. (2006) Aberrant phenotype and function of myeloid dendritic cells in systemic lupus erythematosus. J. Immunol. 177, 5878–5889.
Gota, C. and Calabrese, L. (2003) Induction of clinical autoimmune disease by therapeutic interferon-alpha. Autoimmunity 36, 511–518.
Hron, J.D. and Peng, S.L. (2004) Type I IFN protects against murine lupus. J. Immunol. 173, 2134–2142.
Hudgins, C.C., Steinberg, R.T., Klinman, D.M., Reeves, M.J. and Steinberg, A.D. (1985) Studies of consomic mice bearing the Y chromosome of the BXSB mouse. J. Immunol. 134, 3849–3854.
Iwasaki, A. and Medzhitov, R. (2004) Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5, 987–995.
Izui, S. (1990) Autoimmune accelerating genes, lpr and Yaa, in murine systemic lupus erythematosus. Autoimmunity 6, 113–129.
Izui, S., Higaki, M., Morrow, D. and Merino, R. (1988) The Y chromosome from autoimmune BXSB/MpJ mice induces a lupus-like syndrome in (NZW x C57BL/6)F1 male mice, but not in C57BL/6 male mice. Eur. J. Immunol. 18, 911–915.
Kong, P.L., Morel, L., Croker, B.P. and Craft, J. (2004) The centromeric region of chromosome 7 from MRL mice (Lmb3) is an epistatic modifier of Fas for autoimmune disease expression. J. Immunol. 172, 2785–2794.
Kono, D.H. and Theofilopoulos, A.N. (2000) Genetics of systemic autoimmunity in mouse models of lupus. Int. Rev. Immunol. 19, 367–387.
Kumar, K.R., Li, L., Yan, M., Bhaskarabhatla, M., Mobley, A.B., Nguyen, C., Mooney, J.M., Schatzle, J.D., Wakeland, E.K. and Mohan, C. (2006) Regulation of B cell tolerance by the lupus susceptibility gene Ly108. Science 312, 1665–1669.
Li, J., Liu, Y., Xie, C., Zhu, J., Kreska, D., Morel, L. and Mohan, C. (2005) Deficiency of type I interferon contributes to Sle2-associated component lupus phenotypes. Arthritis Rheum. 52, 3063–3072.
Meylan, E., Tschopp, J. and Karin, M. (2006) Intracellular pattern recognition receptors in the host response. Nature 442, 39–44.
Mohan, C., Alas, E., Morel, L., Yang, P. and Wakeland, E.K. (1998a) Genetic dissection of SLE pathogenesis. Sle1 on murine chromosome 1 leads to a selective loss of tolerance to H2A/H2B/DNA subnucleosomes. J. Clin. Invest. 101, 1362–1372.
Mohan, C., Morel, L., Yang, P. and Wakeland, E.K. (1998b) Accumulation of splenic B1a cells with potent antigen-presenting capability in NZM2410 lupus-prone mice. Arthritis Rheum. 41, 1652–1662.
Mohan, C., Morel, L., Yang, P. and Wakeland, E.K. (1997) Genetic dissection of systemic lupus erythematosus pathogenesis: Sle2 on murine chromosome 4 leads to B cell hyperactivity. J. Immunol. 159, 454–465.
Mohan, C., Morel, L., Yang, P., Watanabe, H., Croker, B., Gilkeson, G. and Wakeland, E.K. (1999a) Genetic dissection of lupus pathogenesis: a recipe for nephrophilic autoantibodies. J. Clin. Invest. 103, 1685–1695.
Mohan, C., Yu, Y., Morel, L., Yang, P. and Wakeland, E.K. (1999b) Genetic dissection of Sle pathogenesis: Sle3 on murine chromosome 7 impacts T cell activation, differentiation, and cell death. J. Immunol. 162, 6492–6502.
Morel, L., Blenman, K.R., Croker, B.P. and Wakeland, E.K. (2001) The major murine systemic lupus erythematosus susceptibility locus, Sle1, is a cluster of functionally related genes. Proc. Natl. Acad. Sci. U.S.A. 98, 1787–1792.
Morel, L., Croker, B.P., Blenman, K.R., Mohan, C., Huang, G., Gilkeson, G. and Wakeland, E.K. (2000) Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc. Natl. Acad. Sci. U.S.A. 97, 6670–6675.
Morel, L., Mohan, C., Yu, Y., Croker, B.P., Tian, N., Deng, A. and Wakeland, E.K. (1997) Functional dissection of systemic lupus erythematosus using congenic mouse strains. J. Immunol. 158, 6019–6028.
Morel, L., Rudofsky, U.H., Longmate, J.A., Schiffenbauer, J. and Wakeland, E.K. (1994) Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1, 219–229.
Morel, L. and Wakeland, E.K. (2000) Lessons from the NZM2410 model and related strains. Int. Rev. Immunol. 19, 423–446.
Morel, L., Yu, Y., Blenman, K.R., Caldwell, R.A. and Wakeland, E.K. (1996) Production of congenic mouse strains carrying genomic intervals containing SLE-susceptibility genes derived from the SLE-prone NZM2410 strain. Mamm. Genome 7, 335–339.
Murphy, E.D. and Roths, J.B. (1979) A Y chromosome associated factor in strain BXSB producing accelerated autoimmunity and lymphoproliferation. Arthritis Rheum. 22, 1188–1194.
Nath, S.K., Kilpatrick, J. and Harley, J.B. (2004) Genetics of human systemic lupus erythematosus: the emerging picture. Curr. Opin. Immunol. 16, 794–800.
Neighbour, P.A. and Grayzel, A.I. (1981) Interferon production of vitro by leucocytes from patients with systemic lupus erythematosus and rheumatoid arthritis. Clin. Exp. Immunol. 45, 576–582.
Pisitkun, P., Deane, J.A., Difilippantonio, M.J., Tarasenko, T., Satterthwaite, A.B. and Bolland, S. (2006) Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 312, 1669–1672.
Rudofsky, U.H., Evans, B.D., Balaban, S.L., Mottironi, V.D. and Gabrielsen, A.E. (1993) Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization. Lab. Invest. 68, 419–426.
Santiago-Raber, M.L., Baccala, R., Haraldsson, K.M., Choubey, D., Stewart, T.A., Kono, D.H. and Theofilopoulos, A.N. (2003) Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice. J. Exp. Med. 197, 777–788.
Shi, X., Xie, C., Kreska, D., Richardson, J.A. and Mohan, C. (2002) Genetic dissection of SLE: SLE1 and FAS impact alternate pathways leading to lymphoproliferative autoimmunity. J. Exp. Med. 196, 281–292.
Sobel, E.S., Mohan, C., Morel, L., Schiffenbauer, J. and Wakeland, E.K. (1999) Genetic dissection of SLE pathogenesis: adoptive transfer of Sle1 mediates the loss of tolerance by bone marrow-derived B cells. J. Immunol. 162, 2415–2421.
Sobel, E.S., Morel, L., Baert, R., Mohan, C., Schiffenbauer, J. and Wakeland, E.K. (2002) Genetic dissection of systemic lupus erythematosus pathogenesis: evidence for functional expression of Sle3/5 by non-T cells. J. Immunol. 169, 4025–4032.
Steinberg, R.T., Miller, M.L. and Steinberg, A.D. (1985) Effect of the BXSB Y chromosome accelerating gene on autoantibody production. Clin. Immunol. Immunopathol. 35, 67–72.
Stetson, D.B. and Medzhitov, R. (2006) Type I interferons in host defense. Immunity 25, 373–381.
Subramanian, S., Tus, K., Li, Q.Z., Wang, A., Tian, X.H., Zhou, J., Liang, C., Bartov, G., McDaniel, L.D., Zhou, X.J., Schultz, R.A. and Wakeland, E.K. (2006) A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc. Natl. Acad. Sci. U.S.A. 103, 9970–9975.
Tsao, B.P., Cantor, R.M., Grossman, J.M., Shen, N., Teophilov, N.T., Wallace, D.J., Arnett, F.C., Hartung, K., Goldstein, R., Kalunian, K.C., Hahn, B.H. and Rotter, J.I. (1999) PARP alleles within the linked chromosomal region are associated with systemic lupus erythematosus. J. Clin. Invest. 103, 1135–1140.
Vyse, T.J. and Kotzin, B.L. (1998) Genetic susceptibility to systemic lupus erythematosus. Ann. Rev. Immunol. 16, 261–292.
Wakeland, E.K., Liu, K., Graham, R.R. and Behrens, T.W. (2001) Delineating the genetic basis of systemic lupus erythematosus. Immunity 15, 397–408.
Wakeland, E.K., Wandstrat, A.E., Liu, K. and Morel, L. (1999) Genetic dissection of systemic lupus erythematosus. Curr. Opin. Immunol. 11, 701–707.
Wakui, M., Kim, J., Butfiloski, E.J., Morel, L. and Sobel, E.S. (2004) Genetic dissection of lupus pathogenesis: Sle3/5 impacts IgH CDR3 sequences, somatic mutations, and receptor editing. J. Immunol. 173, 7368–7376.
Wandstrat, A.E., Nguyen, C., Limaye, N., Chan, A.Y., Subramanian, S., Tian, X.H., Yim, Y.S., Pertsemlidis, A., Garner, H.R., Jr., Morel, L. and Wakeland, E.K. (2004) Association of extensive polymorphisms in the SLAM/CD2 gene cluster with murine lupus. Immunity 21, 769–780.
Xu, Z., Duan, B., Croker, B.P., Wakeland, E.K. and Morel, L. (2005) Genetic dissection of the murine lupus susceptibility locus Sle2: contributions to increased peritoneal B-1a cells and lupus nephritis map to different loci. J. Immunol. 175, 936–943.
Zhu, J., Liu, X., Xie, C., Yan, M., Yu, Y., Sobel, E.S., Wakeland, E.K. and Mohan, C. (2005) T cell hyperactivity in lupus as a consequence of hyperstimulatory antigen-presenting cells. J. Clin. Invest. 115, 1869–1878.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Science+Business Media, LLC
About this paper
Cite this paper
Zhu, J., Mohan, C. (2007). SLE 1, 2, 3…Genetic Dissection of Lupus. In: Shurin, M.R., Smolkin, Y.S. (eds) Immune-Mediated Diseases. Advances in Experimental Medicine and Biology, vol 601. Springer, New York, NY. https://doi.org/10.1007/978-0-387-72005-0_9
Download citation
DOI: https://doi.org/10.1007/978-0-387-72005-0_9
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-72004-3
Online ISBN: 978-0-387-72005-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)